LcProt: Proteomics Longitudinal Cohort Study on Lung CancerProspective Longitudinal Cohort Study of Lung Cancer Based on Peripheral Blood and Tissue Proteomics
This study will utilize tissue and peripheral blood samples for proteomics analysis and establish a longitudinal proteomics cohort at multiple critical treatment time points to explore the research value of proteomics in the diagnosis and treatment of lung cancer. The study includes key time points such as screening, postoperative efficacy prediction, and efficacy prediction after medication.
• Signing of the informed consent form;
• Male or female, aged 18-75 years;
• Patients with lung nodules confirmed by CT examination;
• Good preoperative pulmonary function cooperation and complete reporting;
• Preoperative chest single/dual phase CT scans without significant artefacts and with complete imaging;
• The interval between preoperative pulmonary function and single/dual phase CT scans does not exceed one month.